1. Targeting Siglec–Sialylated MUC1 Immune Axis in Cancer
   Ramya Ayyalasomayajula et al, 2024, Cancers CrossRef
2. The Role of MUC1 in Renal Cell Carcinoma
   Martina Milella et al, 2024, Biomolecules CrossRef
3. A Case of Solitary Pancreatic Metastasis from Gallbladder Cancer
   Shinya Kosuge et al, 2023, The Japanese Journal of Gastroenterological Surgery CrossRef
4. Immunoengineering can overcome the glycocalyx armour of cancer cells
   Sangwoo Park et al, 2024, Nature Materials CrossRef
5. MUC1 promotes cancer stemness and predicts poor prognosis in osteosarcoma
   Jian Liu et al, 2023, Pathology - Research and Practice CrossRef
6. Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
   Wojciech Szymanowski et al, 2023, Cancers CrossRef
7. Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments
   Maurizio Capuozzo et al, 2024, Molecular and Cellular Probes CrossRef
8. Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease
   Berna Tumoglu et al, 2023, Glycobiology CrossRef
9. Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer
   Anupam Dhasmana et al, 2023, Computational and Structural Biotechnology Journal CrossRef
10. A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis
    Mutsumi Fujimoto et al, 2023, Surgical Case Reports CrossRef
11. Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer
    Kenji Nakahama et al, 2023, Cancer Chemotherapy and Pharmacology CrossRef
12. Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials
    Muhammet Ozer et al, 2023, Cancers CrossRef
13. Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
    Aying Wang et al, 2023, Cellular Immunology CrossRef